| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 598 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 558 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 552 | 2024 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 551 | 2023 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 514 | 2024 |
| Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 M Naghavi, SE Vollset, KS Ikuta, LR Swetschinski, AP Gray, EE Wool, ... The Lancet 404 (10459), 1199-1226, 2024 | 428 | 2024 |
| Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects S Kacimi, A Ref'at, MA Fararjeh, YK Bustanji, MK Mohammad, ML Salem Nutrition research 32 (12), 947-955, 2012 | 391 | 2012 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 336 | 2024 |
| Self-medication patterns in Amman, Jordan AMM Yousef, AG Al-Bakri, Y Bustanji, M Wazaify Pharmacy World & Science 30, 24-30, 2008 | 322 | 2008 |
| Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area M Hudaib, M Mohammad, Y Bustanji, R Tayyem, M Yousef, M Abuirjeie, ... Journal of Ethnopharmacology 120 (1), 63-71, 2008 | 271 | 2008 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 247 | 2024 |
| Inhibition of hormone sensitive lipase and pancreatic lipase by Rosmarinus officinalis extract and selected phenolic constituents Y Bustanji, A Issa, M Mohammad, M Hudaib, K Tawah, H Alkhatib, ... J Med Plants Res 4 (21), 2235-42, 2010 | 156 | 2010 |
| Pancreatic lipase inhibition activity of trilactone terpenes of Ginkgo biloba Y Bustanji, IM Al-Masri, M Mohammad, M Hudaib, K Tawaha, H Tarazi, ... Journal of Enzyme Inhibition and Medicinal Chemistry 26 (4), 453-459, 2011 | 136 | 2011 |
| Community consumption of antibacterial drugs within the Jordanian population: sources, patterns and appropriateness AG Al-Bakri, Y Bustanji, AM Yousef International Journal of Antimicrobial Agents 26 (5), 389-395, 2005 | 132 | 2005 |
| The assessment of the antibacterial and antifungal activities of aspirin, EDTA and aspirin–EDTA combination and their effectiveness as antibiofilm agents AG Al‐Bakri, G Othman, Y Bustanji Journal of applied microbiology 107 (1), 280-286, 2009 | 130 | 2009 |
| Adiponectin Serum Levels Correlate with Insulin Resistance in Type 2 Diabetic Patients S Aleidi, A Issa, H Bustanji, M Khalil, Y Bustanji Saudi Pharmaceutical Journal 23, 250-256, 2015 | 127 | 2015 |
| Dynamics of the interaction between a fibronectin molecule and a living bacterium under mechanical force Y Bustanji, CR Arciola, M Conti, E Mandello, L Montanaro, B Samorí Proceedings of the National Academy of Sciences 100 (23), 13292-13297, 2003 | 127 | 2003 |
| In Vitro Xanthine Oxidase Inhibition by Selected Jordanian Medicinal Plants Y Bustanji, M Hudaib, K Tawaha, MK Mohammad, I Almasri, S Hamed, ... Jordan Journal of Pharmaceutical Science 4 (1), 49-56, 2011 | 123* | 2011 |
| Pharmacophore modeling, quantitative structure–activity relationship analysis, and in silico screening reveal potent glycogen synthase kinase-3β inhibitory activities for … MO Taha, Y Bustanji, MAS Al-Ghussein, M Mohammad, H Zalloum, ... Journal of medicinal chemistry 51 (7), 2062-2077, 2008 | 122 | 2008 |
| Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation Y Bustanji, MO Taha, IM Almasri, MAS Al-Ghussein, MK Mohammad, ... Journal of enzyme inhibition and medicinal chemistry 24 (3), 771-778, 2009 | 115 | 2009 |
Mohammad MohammadFaculty of Pharmacy, The University of JordanVerified email at ju.edu.jo
